United States to India: Formoterol Import Trade Route

The United States to India Formoterol corridor is one of India's established pharmaceutical import routes from United States, with 58 shipments documented worth a combined $707.7K USD. The route is dominated by M/S. PAREXEL INTERNATIONAL, which alone accounts for roughly 26% of all import value, reflecting the consolidated nature of United States's formoterol export sector.

Across 24 active United States suppliers, the average shipment value stands at $12.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with formoterol's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 22.3%, placing it at rank #13 among India's top formoterol import origins globally.

On the Indian buyer side, key Indian importers include CIPLA LIMITED, LUPIN LIMITED, CIPLA LIMITED. and 14 others. CIPLA LIMITED is the single largest Indian importer with 7 shipments valued at $267.8K USD.

India's formoterol imports from United States are driven primarily by a handful of large-scale United States manufacturers. M/S. PAREXEL INTERNATIONAL with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 24 active exporters signals a competitive but concentrated market — Indian buyers benefit from United States supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M/S. PAREXEL INTERNATIONAL, M/S. NORTH AMERICAN DISTRIBUTION CE, ESPEE BIOPHARMA & FINECHEM LLC — together account for 54% of total trade value on this route. The average shipment value of $12.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as budesonide/formoterol fumarate dihydrate 80/4.5g inhalation aerosol or placebo-n220054 and mometasone furoate and formoterol fumarate dihydrate inhalation aerosol 100 mcg 5mcg dulera 100mcg 5mcg foc ncv mometasone furoate and formoterol fumarate dihydrate inhal, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United States supplier.

On the buying side, CIPLA LIMITED is the largest importer with 7 shipments worth $267.8K USD — representing 38% of all formoterol imports from United States on this route. A total of 17 buyers are active on this corridor.